ACAAI 2016 Annual Scientific Meeting
Practice Advancement
New times, New Treatments. New standards.
Target Audience
- All practicing allergists/immunologists
- Fellows in allergy/immunology training programs
- Primary care physicians who care for allergy patients
- Allied health professionals in the field of allergy and immunology
Learning Objectives
At the conclusion of this activity, participants should be able to:
- Identify major advances in key areas of cutting edge research in immunologic mechanisms and allergic responses, including anaphylaxis and pathophysiology of the upper airways, lungs, eyes, skin and gastrointestinal tract
- Demonstrate knowledge of basic processes linking molecular and cellular biology and genetics with allergic pathophysiology and immunodeficiency
- Translate emerging clinical science principles to clinical practice in patients with allergic and immunologic diseases
- Evaluate and implement state-of-the-art diagnostic and therapeutic strategies for treating patients with allergic and immunologic diseases
- Explain the impact of environmental exposures and external influences on patients with allergic disorders
- Recognize emerging trends in the prevalence of allergic and immunologic disorders and discuss their impact on public health
- Evaluate the impact of new diagnostic and therapeutic strategies on health care costs and outcomes
- Discuss processes, tools and technologies for the efficient allergy and immunology practice
All identified conflicts of interest have been resolved.
Grant Anhalt, PhD
Consultant/Advisory Board: GlaxoSmithKline
Noga Askenazi, MD FACAAI
Stock: Johnson and Johnson
Amal Assa'ad, MD, FACAAI
Consultant/Advisory Board: Mead Johnson; Research Grant: DBV Technologies, Genentech, GlaxoSmithKline, Teva
Leonard Bacharier, MD, FACAAI
Consultant/Advisory Board: DVB Technologies, Merck, Teva; Speaker: Aerocrine, GlaxoSmithKline, Merck
Sami L. Bahna, MD, DrPH, FACAAI
Consultant/Advisory Board: Abbott; Speaker: Abbott; Honorarium: Abbott
Gregory Bensch, MD, FACAAI
Consultant, Speaker: Teva; Speaker: AstraZeneca.
William E. Berger, MD, MBA, FACAAI
Consultant/Advisory Board: Alcon, AstraZeneca, GlaxoSmithKline, Meda, Novartis, Sunovion, Teva; Speaker: Alcon, AstraZeneca, GlaxoSmithKline, Meda, Novartis, Sunovion, Teva; Honorarium: Alcon, AstraZeneca, GlaxoSmithKline, Meda, Novartis, Sunovion, Teva; Research Grant: Alcon, AstraZeneca, GlaxoSmithKline, Meda, Novartis, Sunovion, Teva
Jonathan A. Bernstein, MD, FACAAI
Consultant/Advisory Board: CSL Behring, Dyax, Meda, Shire, ViroPharma; Speaker: CSL Behring, Dyax, Meda, Shire, Teva, ViroPharma; Honorarium: CSL Behring, Dyax, Meda, Shire, Teva, Viropharma; Research Grant: CSL Behring, Dyax, Novartis, Shire, ViroPharma
Leonard Bielory, MD, FACAAI
Consultant/Advisory Board: Allergan, Bausch & Lomb, Merck, Pharmacal, Sanofi-Chattem; Speaker: Allergan, Bausch & Lomb, Merck; Honorarium: Allergan, Bausch & Lomb, Merck; Research Grant: Allergan, EPA; Stock: STARxTech
Clifton O. Bingham, III, MD
Consultant/Advisory Board: Abbvie, Amgen, Bristol-Myers Squibb, Celgene, Genentech, Roche, Janssen, Novartis, Novo Nordisk, Pfizer, UCB; Research Grant: Bristol-Myers Squibb, Janssen, UCB
Michael S. Blaiss, MD, FACAAI
Consultant/Advisory Board: Alcon, Allergan, Bausch & Lomb, Genentech, GlaxoSmithKline, JDP Therapeutics, Merck, Mylan, Pfizer, PMD Healthcare, Proctor & Gamble, Sanofi, Sunovion, Takeda, Teva; Speaker: Alcon, Allergan, AstraZeneca, Bausch & Lomb, Genentech, GlaxoSmithKline, Merck, Sunovion, Takeda
Don A. Bukstein, MD, FACAAI
Speaker: Aerocrine, AstraZeneca, Genentech, Merck, Novartis, Sunovion, Teva
A. Wesley Burks, MD, FACAAI
Consultant/Advisory Board: Dow AgroSciences, ExploraMed Development, Genalyte, Hycor, Mastcell Pharma, Merck, Nordic Biotech, Novartis, Perrigo Company, Regeneron, Unilever; Speaker: Mylan Specialty; Research Grant: Hycor; Stock: Allertein, Mylan Specialty
Peter A. Calabresi, MD
Consultant/Advisory Board: Abbott, Vertex; Honorarium: Abbott, Vertex; Research Grant: Abbott, Bayer, Biogen Idec, Novartis, Vertex
Warner W. Carr, MD, FACAAI
Consultant/Advisory Board: Alcon, Allergan, Indegene, Meda; Speaker: Alcon, AstraZeneca, Meda, Teva; Honorarium: Alcon, Allergan, AstraZeneca, Indegene, Meda, Teva; Research Grant: Adrea, Forest, Sunovion
Thomas B. Casale, MD, FACAAI
Consultant/Advisory Board: Genentech, Novartis
Adrian M. Casillas, MD, FACAAI
Research Grant: CSL Behring
Bradley E. Chipps, MD, FACAAI
Consultant/Advisory Board: AstraZeneca, Mylan Specialty, Genentech, GlaxoSmithKline, Merck, Novartis, Sunovion; Speaker: AstraZeneca, Bausch & Lomb, Genentech, GlaxoSmithKline, Merck, Novartis, Sunovion; Honorarium: AstraZeneca, Bausch & Lomb, Mylan Specialty, Genentech, GlaxoSmithKline, Merck, Novartis, Sunovion
Mark L. Corbett, MD, FACAAI
Speaker: AstraZeneca, Merck, Sunovion, Teva
Linda Cox, MD, FACAAI
Consultant/Advisory Board: Genentech, Stallergenes; Speaker: Stallergenes
Timothy M Craig, DO, FACAAI
Consultant/Advisory Board: CSL Behring, Dyax. Merck; Speaker: CSL Behring, Dyax, Genentech/Novartis, Merck, Shire, ViroPharma; Honorarium: CSL Behring, Dyax, Genentech/Novartis, Merck, Shire, ViroPharma; Research Grant: CSL Behring, Dyax, Genentech/Novartis, GlaxoSmithKline, Merck, Pharming, Shire, ViroPharma
Peter S. Creticos, MD
Consultant/Advisory Board: Circassia, Greer, Merck; Research Grant: Circassia, Greer, Merck
Chitra Dinakar, MD, FACCAI
Speaker: Aerocrine, Teva; Honorarium: Aerocrine, Teva
Paul Dowling, MD, FACAAI
Speaker: Research Grant: GlaxoSmithKline, Merck
Mark S. Dykewicz, MD, FACAAI
Consultant/Advisory Board: Merck; Honorarium: Merck
Daniel Ein, MD, FACAAI
Consultant/Advisory Board: Allergan
Renata Engler, MD, FACAAI
Research Grant: National Institutes of Health, Stock: Stellar Biotech
Stanley M. Fineman, MD, MBA, FACAAI
Speaker: AstraZeneca, Genentech/Novartis, Sunovion; Research Grant: Genentech/Novartis, Shionogi, Sunovion
Michael B. Foggs, MD, FACAAI
Consultant/Advisory Board: AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Hycor, Merck; Speaker: AstraZeneca, GlaxoSmithKline, Merck; Honorarium: AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Hycor, Merck
Luz S. Fonacier, MD, FACAAI
Speaker: Baxter; Honorarium: Genentech; Research Grant: Baxter, Dyax, Genentech, Merck
Pinkus Goldberg, FACAAI
Consultant/Advisory Board: Allergan; Speaker: Genentech, Meda, Merck, Mylan, Novartis; Research Grant: Circassia, Genentech, GlaxoSmithKline, Meda, Merck, Novartis, Teva
Richard G. Gower, MD, FACAAI
Consultant/Advisory Board: Bausch & Lomb, CSL Behring, Mylan Specialty, Dyax, Genentech, HollisterStier, Mylan, Novartis, Roche, Sanofi, Shire, Teva, ViroPharma; Speaker: Bausch & Lomb, CSL Behring, Mylan, Genentech, Novartis, Roche, Shire, Teva, ViroPharma; Honorarium: Bausch & Lomb, CSL Behring, Genentech, Mylan, Novartis, Roche, Shire, Teva, ViroPharma; Research Grant: Bausch & Lomb, Boehringer Ingelheim, Circassia, CSL Behring, Eli Lilly, Genentech, GlaxoSmithKline, Green Cross, Kedrion, Mylan, Novartis, Pharming, Roche, Shire, Teva, ViroPharma; Stock: Merck
Matthew Greenhawt, MD, MBA, MSc
Consultant/Advisory Board: Nutricia; Research Grant: National Institutes of Health; Speaker: Nutricia; Honorarium: Nutricia
Vivian Hernandez-Trujillo, MD, FACAAI
Consultant/Advisory Board: Baxter, Merck, Sanofi; Speaker: Baxter, CSL Behring, Merck, Sanofi
Lewis Kanter, MD, FACAAI
Speaker: Alcon, Meda, Sunovion, Teva
Rohit K. Katial, MD, FACAAI
Consultant/Advisory Board: Teva; Honorarium: Teva
David A. Khan, MD, FACAAI
Speaker: Baxter, Genentech, Merck, ViroPharma; Honorarium: Baxter, Genentech, Merck, ViroPharma
Monica Kraft, MD
Research Grant: Boston Scientific, Eumedics, Genentech, GlaxoSmithKline, Merck, National Institutes of Health, Novartis
Charles J. Lane, MD
Speaker: GlaxoSmithKline; Honorarium: Mylan Specialty
Bobby Q. Lanier, MD, FACAAI
Consultant/Advisory Board: Merck, Novartis; Speaker: Merck, Novartis; Research Grant: Teva
James T. Li, MD, PhD, FACAAI
Stocks: Abbott, Johnson & Johnson, Novartis
Phillip L. Lieberman, MD, FACAAI
Consultant/Advisory Board: Meda, Mylan, Sanofi; Speaker: Meda, Mylan; Honorarium: Meda, Mylan
Todd A. Mahr, MD, FACAAI
Consultant/Advisory Board: Mylan, Sanofi; Speaker: Aerocrine, Genentech, GlaxoSmithKline, Mylan, Sanofi; Honorarium: Aerocrine, Genentech, GlaxoSmithKline, Mylan, Sanofi
Lyndon Mansfield, MD, FACAAI
Consultant/Advisory Board: Genentech; Speaker: Sunovion, Teva
Gailen D. Marshall, Jr., MD, PhD, FACP, FACAAI
Research Grant: Teva, National Institutes of Health, Health Resources and Services Administration
Kevin P. McGrath, MD, FACAAI
Speaker: Sunovion
Travis A. Miller, MD, FACAAI
Consultant/Advisory Board: Meda, Sunovion; Speaker: Alcon, AstraZeneca, Bausch & Lomb, GlaxoSmithKline, Meda, Merck, Mylan, Novartis, Sunovion, Teva; Honorarium: Alcon, AstraZeneca, GlaxoSmithKline, Meda, Merck, Mylan, Novartis, Sunovion; Teva
Anthony Montanaro, MD, FACAAI
Research Grant: Boehringer Ingelheim, Genentech, GlaxoSmithKline, Merck, Novartis, Teva
Harold S. Nelson, MD, FACAAI
Consultant/Advisory Board: Merck, Shionogi: Honorarium: Merck, Pearl, Shionogi; Research Grant: Circassia, Lincoln Diagnostics, Rigel
Talal M. Nsouli, MD, FACAAI
Consultant/Advisory Board: Thermo Fisher Scientific, Sunovion, Teva; Speaker: Thermo Fisher Scientific, Sunovion, Teva
John J. Oppenheimer, MD, FACAAI
Consultant/Advisory Board: AstraZeneca, GlaxoSmithKline, Mylan, Sunovion; Research Grant: AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline
Nancy K. Ostrom, MD, FACAAI
Consultant/Advisory Board: Bausch & Lomb, Meda, Merck, Teva; Speaker: AstraZeneca, GlaxoSmithKline, Meda, Merck, Novartis, Sunovion, Teva; Research Grant: Apotex, AstraZeneca, Boehringer Ingelheim, ElectroCore, GlaxoSmithKline, MedImmune, Merck, Nestle, Novartis, Rigel, Sunovion, Teva, Actavis
Thomas A.E. Platts-Mills, MD, PhD, FACAAI
Consultant/Advisory Board: ViraCor-IBT, Speaker: ALK-Abello; Honorarium: ALK-Abello, Thermo Fisher Scientific; Research Grant: Thermo Fisher Scientific
Jay M. Portnoy, MD, FACAAI
Consultant/Advisory Board: Sanofi, Thermo Fisher Scientific; Speaker: Mylan, Thermo Fisher Scientific; Honorarium: Mylan, Sanofi, Thermo Fisher Scientific
Marc A. Riedl, MD, MS
Consultant/Advisory Board: BioCryst, CSL Behring, Dyax, Shire, ViroPharma; Speaker: CSL Behring, Dyax, Shire, ViroPharma; Research Grant: CSL Behring, Dyax, Shire, ViroPharma
Ketan Sheth, MD, MBA, FACAAI
Consultant/Advisory Board: Teva; Speaker: GlaxoSmithKline, Teva; Honorarium: GlaxoSmithKline, Teva; Stocks: Merck
Charles J. Siegel, MD, FACAAI
Consultant/Advisory Board: Meda, Teva; Speaker: Meda, Teva; Honorarium: Meda, Mylan, Teva
David P. Skoner, MD, FACAAI
Consultant/Advisory Board: Bausch & Lomb, Merck, Sunovion; Speaker: GlaxoSmithKline, Merck, Novartis, Sunovion, Teva; Research Grant: GlaxoSmithKline, Greer, Merck, Novartis, Teva
Brett E. Stanaland, MD, MS, FACAAI
Consultant/Advisory Board: Sunovion, Teva; Speaker: Meda, Merck, Sunovion, Teva
Gary C. Steven, MD, PhD, FACAAI
Speaker: Merck, Novartis, Teva; Research Grant: Merck, AstraZeneca, Circassia, Genentech, Mylan, Novartis, Novum, Optinose, Concentric, Pulmagen, GlaxoSmithKline, Teva
James L. Sublett, MD, FACAAI
Consultant/Advisory Board: Aerocrine, GlaxoSmithKline, Meda, Merck, Sunovion, Teva; Speaker: GlaxoSmithKline, Merck, Sunovion, Teva; Honorarium: GlaxoSmithKline, Merck, Sunovion, Teva; Research Grant: GlaxoSmithKline, Merck, Novartis, Sunovion, Teva,
Stanley J. Szefler, MD, FACAAI
Consultant/Advisory Board: Boehringer Ingelheim, GlaxoSmithKline, Merck, Roche; Speaker: Merck; Honorarium: Genentech; Research Grant: Boehringer Ingelheim, GlaxoSmithKline
Stephen A. Tilles, MD FACAAI
Consultant/Advisory Board: Bausch & Lomb, Hycor, Merck, Mylan, Sunovion
Janna M. Tuck, MD, FACAAI
Stocks: Advanced Cell Technology, Cel-Sci, Synergy
Dana V. Wallace, MD, FACAAI
Consultant/Advisory Board: Bausch & Lomb, Mylan, Sanofi, Sunovion, Teva
Richard W. Weber, MD, FACAAI
Consultant/Advisory Board: Genentech; Speaker: Merck; Research Grant: Novartis
The following have no relevant financial relationships to disclose:
Joseph A. Bellanti, MD, FACAAI
Monica Bhagat, MD
Christina Ciaccio, MD, FACAAI
John O. Clarke, MD
Vesselin Dimov, MD
Nemr S. Eid, MD
Shari M. Erickson, MPH
Alessandro Fiocchi, MD, FACAAI (SC)
Karen A. Freedle, MD, FACAAI
Curtis L. Hedberg, MD, FACAAI
Kirsi Jarvinen-Seppo, MD, PhD
John M. Kelso, MD, FACAAI
Tao T. Le, MD, MHS, FACAAI
Alnoor A. Malick, MD, FACAAI
Jennifer Mammen, MD
Bryan L. Martin, DO, FACAAI
Kathleen May, MD, FACAAI
Michael Nelson, MD, PhD, FACAAI
Myngoc T. Nguyen, MD, FACAAI
Richard A. Nicklas, MD, FACAAI
Maeve O'Connor, MD, FACAAI
Mark T. O'Hollaren, MD, FACAAI
Gurusher Panjrath, MD
Kavita Patel, MD
Joram S. Seggev, MD, FACAAI
Meagan Shepherd, MD
David R. Weldon, MD, FACAAI
Education Staff/Committee/Reviewers have no relevant financial relationships to disclose, except as may be listed above.
Available Credit
- 41.25 AMA PRA Category 1 Credit™
- 41.25 Attendance
- 13.50 MOC